Beneficial ownership percentage.

No definition available.

Name:	sana_BeneficialOwnershipPercentage
Namespace Prefix:	sana_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Gain expense in connection with change in estimated fair value of success payment liabilities.

+ References

No definition available.

+ Details

Name:	sana_GainExpenseInConnectionWithChangeInEstimatedFairValueOfSuccessPaymentLiabilities
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Maximum period expected to achieve for success payments.

+ References

No definition available.

+ Details

Name:	sana_MaximumPeriodExpectedToAchieveForSuccessPayments
Namespace Prefix:	sana_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum potential success payments.

+ References

No definition available.

+ Details

Name:	sana_MaximumPotentialSuccessPayments
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payment to collaborators.

+ References

No definition available.

+ Details

Name:	sana_PaymentToCollaborators
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Potential amount of milestone payments and royalties payable.

+ References

No definition available.

+ Details

Name:	sana_PotentialAmountOfMilestonePaymentsAndRoyaltiesPayable
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Stock issued during period, value, common stock in connection with license agreement.

+ References

No definition available.

+ Details

Name:	sana_StockIssuedDuringPeriodValueCommonStockInConnectionWithLicenseAgreement
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total value of consideration paid under license agreement.

+ References

No definition available.

+ Details

Name:	sana_TotalValueOfConsiderationPaidUnderLicenseAgreement
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Upfront payment to collaborators.

+ References

No definition available.

+ Details

Name:	sana_UpfrontPaymentToCollaborators
Namespace Prefix:	sana_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-2

+ Details

Name:	us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sana_MayoClinicInitialSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sana_StockPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sana_MayoClinicElectionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=sana_BeamTherapeuticsIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=sana_HarvardCollegeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License and Collaboration Agreements - Additional Information (Details) - USD ($)	1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2026	Apr. 30, 2026	Mar. 31, 2019	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2021	Oct. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Net proceeds from issuance of common stock						$ 89,646,000	$ 254,000
Issuance of common stock allocated to stock purchase option				$ 3,688,000
Additional Paid-in Capital
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of common stock allocated to stock purchase option				3,688,000
Mayo Clinic Initial Shares \| Stock Purchase Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Stock price price per share		$ 3.33
Net proceeds from issuance of common stock		$ 25,000,000
Mayo Clinic Initial Shares \| Stock Purchase Agreement \| Common Stock and Additional Paid-in Capital
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of common stock allocated to stock purchase option						21,300,000
Mayo Clinic Election \| Stock Purchase Agreement \| Forecast
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Stock price price per share	$ 3.33
Net proceeds from issuance of common stock	$ 25,000,000
Mayo Clinic Election \| Stock Purchase Agreement \| Additional Paid-in Capital
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of common stock allocated to stock purchase option						3,700,000
Beam Therapeutics Inc. (Beam) \| Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Upfront payment to collaborators								$ 50,000,000
Beam Therapeutics Inc. (Beam) \| Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Developmental and commercial milestone payments and royalties on licensed products payable									$ 65,000,000.0
Beam Therapeutics Inc. (Beam) \| Minimum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Beneficial ownership percentage held by a member of board of directors									10.00%
Harvard College
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Share issue price			$ 4.00
Aggregated consideration paid			$ 12,000,000.0
Common stock shares issued			9,000,000.0
Payment to collaborators			$ 3,000,000.0
Maximum period expected to achieve for success payments			12 years
Harvard College \| Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Expense (gain) in connection with change in estimated fair value of success payment liability				$ 400,000	$ 400,000	$ (100,000)	$ 400,000
Harvard College \| Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Cobalt success payment			$ 175,000,000.0